Position in GH
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$8,324,753
+$651,588 QoQ
Shares Held
90,124
+20.0% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $1,035,545,424 across 24 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,339,185 | $255,087,958 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
461,039 | $231,146,511 | |
| 3 | ICLR |
Icon PLC
|
394,362 | $68,504,622 | |
| 4 | WAT |
Waters Corp /De/
|
138,104 | $51,794,522 | |
| 5 | PSNL |
Personalis, Inc.
|
3,747,290 | $50,213,686 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
91,286 | $48,056,601 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
238,810 | $46,142,867 | |
| 8 | A |
Agilent Technologies, Inc.
|
288,030 | $38,259,024 |
All Filings in GH
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,324,753 | 90,124 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $7,673,165 | 75,124 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $7,228,998 | 115,701 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $9,016,502 | 173,261 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $10,776,223 | 252,963 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $13,532,153 | 442,951 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $12,673,730 | 552,473 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $10,789,308 | 373,591 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,444,228 | 457,791 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $9,361,572 | 346,084 | Shares | Defined | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||